Xiaoyi Yin

No.168, Changhai Rd
Shanghai, 200433, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Rewiring metabolic-immune circuitry in pancreatic ductal adenocarcinoma (PDAC).

Rewiring metabolic-immune circuitry in pancreatic ductal adenocarcinoma (PDAC).

Journal: Cancer pathogenesis and therapy

Published: April 22, 2026

Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post- neoadjuvant therapy" [Cancer Lett. (2026), Online ahead of print].

Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post- neoadjuvant therapy" [Cancer Lett. (2026), Online ahead of print].

Journal: Cancer letters

Published: February 06, 2026

T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial.

T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 30, 2025

A mitochondria-related gene-based signature predicts pancreatic ductal adenocarcinoma clinical outcome and revealed CAMK2A/THEM4 regulates progression phenotypes and mitophagy in vivo and in vitro.

A mitochondria-related gene-based signature predicts pancreatic ductal adenocarcinoma clinical outcome and revealed CAMK2A/THEM4 regulates progression phenotypes and mitophagy in vivo and in vitro.

Journal: Journal of translational medicine

Published: August 22, 2025

The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant therapy.

The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post-neoadjuvant therapy.

Journal: Cancer letters

Published: June 28, 2025

Artificial intelligence in oncological imaging screening.

Artificial intelligence in oncological imaging screening.

Journal: International journal of surgery (London, England)

Published: May 31, 2025

Senescence-driven molecular subtyping in pancreatic cancer: a multi-omics framework for precision medicine.

Senescence-driven molecular subtyping in pancreatic cancer: a multi-omics framework for precision medicine.

Journal: BMC cancer

Published: April 04, 2025

Integrated genomics and transcriptomics reveal key events in pancreatic neuroendocrine neoplasm.

Integrated genomics and transcriptomics reveal key events in pancreatic neuroendocrine neoplasm.

Journal: BMC biology

Published: March 28, 2025

Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients.

Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients.

Journal: JCI insight

Published: January 23, 2025

A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma.

A practical distribution pattern of α-SMA-positive carcinoma associated fibroblasts indicates poor prognosis of patients with pancreatic ductal adenocarcinoma.

Journal: Translational oncology

Published: September 10, 2024

Periarterial divestment following neoadjuvant therapy in patients with locally advanced pancreatic cancer with celiac axis invasion: A safe and effective surgical procedure.

Periarterial divestment following neoadjuvant therapy in patients with locally advanced pancreatic cancer with celiac axis invasion: A safe and effective surgical procedure.

Journal: Surgery

Published: August 29, 2024

Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.

Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.

Journal: Nature communications

Published: January 21, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026